Search results
Bio-Path Holdings, Inc. Announces Closing of $1.2 Million Registered Direct Offering Priced...
Morningstar· 9 hours agoBio-Path Holdings, Inc., (Nasdaq: BPTH) (the “Company” or “Bio-Path”), a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle ...
Bio-Path (BPTH) Rises on Upbeat Updates From Blood Cancer Study
Zacks via Yahoo Finance· 11 hours agoBio-Path (BPTH) gains 30% on encouraging developmental updates from the early-stage study of its...
Bio-Rad (BIO) Hurt by Softness in BioPharma and Competition
Zacks via Yahoo Finance· 3 days agoBio-Rad BIO has been facing the impact of funding issues in the biopharmaceutical or BioPharma...
Bio-Techne (NASDAQ:TECH) Price Target Cut to $82.00 by Analysts at Deutsche Bank Aktiengesellschaft
ETF DAILY NEWS· 18 hours agoBio-Techne (NASDAQ:TECH – Free Report) had its target price trimmed by Deutsche Bank Aktiengesellschaft from $85.00 to $82.00 in a research report sent to investors on Thursday ...
Bio-Rad Laboratories (BIO) to Post Q1 Earnings: What Awaits?
Zacks via Yahoo Finance· 1 day agoThe ongoing weakness in the biopharma end markets and tightening of sanctions against Russia is...
Bio-Rad Laboratories, Inc. Forecasted to Earn Q1 2025 Earnings of $2.39 Per Share (NYSE:BIO)
ETF DAILY NEWS· 22 hours agoBio-Rad Laboratories, Inc. (NYSE:BIO – Free Report) – Investment analysts at Zacks Research raised their Q1 2025 earnings per share (EPS) estimates for ...
Bio-Path’s (BPTH) “Buy” Rating Reaffirmed at Roth Mkm
ETF DAILY NEWS· 18 hours agoRoth Mkm reissued their buy rating on shares of Bio-Path (NASDAQ:BPTH – Free Report) in a research note published on Thursday, Benzinga reports. Roth Mkm currently has a $40.00 ...
Major Bio-mechanoid
Fandom· 1 day agoThe Major Bio-mechanoid (colloquially known as the "Walker" by Earth Defense Force soldiers) is a very dangerous enemy featured in many Serious Sam...
Brokerages Set bluebird bio, Inc. (NASDAQ:BLUE) Price Target at $5.87
ETF DAILY NEWS· 23 hours agoThe average 1-year price objective among brokers that have issued ratings on the stock in the last year is $5.87. Wedbush reduced their target price on bluebird bio from $1.72 ...
Telesis Bio stock slips amid new CEO (NASDAQ:TBIO)
Seeking Alpha· 1 day agoTelesis Bio (TBIO) stock slipped as the company promoted its Chief Operating Officer Eric Esser to the CEO role. Read more here.